Company Filing History:
1 out of 2,885 
1 out of 1,187 
Years Active: 2019
Title: Edouard Mullarky: Innovator in Cancer Research
Introduction
Edouard Mullarky is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research through his innovative work on small molecule inhibitors. His research focuses on the enzyme 3-phosphoglycerate dehydrogenase (PHGDH), which plays a crucial role in serine metabolism and cancer progression.
Latest Patents
Mullarky holds a patent for a small molecule inhibitor of 3-phosphoglycerate dehydrogenase and its various applications. The patent outlines methods for treating cancers using these inhibitors, as well as techniques for studying serine metabolism. This invention represents a significant advancement in the development of targeted cancer therapies.
Career Highlights
Throughout his career, Edouard Mullarky has worked with prestigious institutions such as Cornell University and The Scripps Research Institute. His research has garnered attention for its potential to improve cancer treatment options and enhance our understanding of metabolic processes in cancer cells.
Collaborations
Mullarky has collaborated with esteemed colleagues, including Lewis C. Cantley and Costas A. Lyssiotis. These partnerships have contributed to the advancement of research in cancer metabolism and therapeutic strategies.
Conclusion
Edouard Mullarky's innovative work in developing small molecule inhibitors of PHGDH highlights his commitment to advancing cancer research. His contributions have the potential to lead to new treatment options for patients, showcasing the importance of innovation in the medical field.